Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. (AVTX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 76 transactions totaling $18.8M, demonstrating a bullish sentiment with $14.2M in net insider flow. The most recent transaction on Dec 10, 2025 involved a transaction of 155 shares valued at $636.
AVTX Insider Activity Summary
Who Is Buying AVTX Stock?
No significant insider buying has been recorded for AVTX in the recent period.
Who Is Selling AVTX Stock?
No significant insider selling has been recorded for AVTX in the recent period.
Is Avalo Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AVTX is bullish with an Insider Alignment Score of 88/100 and a net flow of $14.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AVTX Frequently Asked Questions
Understanding AVTX Insider Activity
Insider trading at Avalo Therapeutics, Inc. (AVTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading AVTX stock, having executed 76 transactions in the past 90 days. The most active insider is Capital, Llc Armistice (Executive), who has made 11 transactions totaling $13.0M.
Related Tools
Track Avalo Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AVTX file new Form 4 transactions